Pruthi RS - Search Results

1

Roadmap for the development of the University of North Carolina at Chapel Hill Genitourinary OncoLogy Database--UNC GOLD.

Gallagher SA, Smith AB, Matthews JE, Potter CW, Woods ME, Raynor M, Wallen EM, Rathmell WK, Whang YE, Kim WY, Godley PA, Chen RC, Wang A, You C, Barocas DA, Pruthi RS, Nielsen ME, Milowsky MI. Gallagher SA, et al. Among authors: pruthi rs. Urol Oncol. 2014 Jan;32(1):32.e1-9. doi: 10.1016/j.urolonc.2012.11.019. Epub 2013 Feb 19. Urol Oncol. 2014. PMID: 23434424 Free PMC article.

2

Partial nephrectomy with fibrin glue repair: measurement of vascular and pelvicaliceal hydrodynamic bond integrity in a live and abbatoir porcine model.

Kouba E, Tornehl C, Lavelle J, Wallen E, Pruthi RS. Kouba E, et al. Among authors: pruthi rs. J Urol. 2004 Jul;172(1):326-30. doi: 10.1097/01.ju.0000123823.27846.d7. J Urol. 2004. PMID: 15201805

3

Rationale for use of cyclooxygenase-2 inhibitors in prevention and treatment of bladder cancer.

Pruthi RS, Derksen E, Gaston K, Wallen EM. Pruthi RS, et al. Urology. 2004 Oct;64(4):637-42. doi: 10.1016/j.urology.2004.04.047. Urology. 2004. PMID: 15491687 Review. No abstract available.

4

Impact of race, age, income, and residence on prostate cancer knowledge, screening behavior, and health maintenance in siblings of patients with prostate cancer.

Pruthi RS, Tornehl C, Gaston K, Lee K, Moore D, Carson CC, Wallen EM. Pruthi RS, et al. Eur Urol. 2006 Jul;50(1):64-9. doi: 10.1016/j.eururo.2005.09.024. Epub 2005 Dec 12. Eur Urol. 2006. PMID: 16364537

5

Cyclooxygenase-2: a therapeutic target for prostate cancer.

Pruthi RS, Wallen EM. Pruthi RS, et al. Clin Genitourin Cancer. 2005 Dec;4(3):203-11. doi: 10.3816/CGC.2005.n.034. Clin Genitourin Cancer. 2005. PMID: 16425990 Review.

6

Large presacral schwannoma after radical prostatectomy.

Pruthi RS, Hubbard JS, Kouba E, Funkhouser W, Wallen E. Pruthi RS, et al. Eur Urol. 2006 May;49(5):914-7. doi: 10.1016/j.eururo.2006.01.057. Epub 2006 Feb 24. Eur Urol. 2006. PMID: 16524659

7

Phase II trial of celecoxib in prostate-specific antigen recurrent prostate cancer after definitive radiation therapy or radical prostatectomy.

Pruthi RS, Derksen JE, Moore D, Carson CC, Grigson G, Watkins C, Wallen E. Pruthi RS, et al. Clin Cancer Res. 2006 Apr 1;12(7 Pt 1):2172-7. doi: 10.1158/1078-0432.CCR-05-2067. Clin Cancer Res. 2006. PMID: 16609031 Clinical Trial.

8

Virtual pyeloscopy using volumetric depth peeling.

Fielding JR, Borland D, Lee KH, Clarke JP, Wallen E, Pruthi R, Taylor RM. Fielding JR, et al. Acad Radiol. 2006 Jun;13(6):759-63. doi: 10.1016/j.acra.2006.02.042. Acad Radiol. 2006. PMID: 16679279

9

Characterization of biochemical recurrence after radical prostatectomy.

Molitierno J, Evans A, Mohler JL, Wallen E, Moore D, Pruthi RS. Molitierno J, et al. Among authors: pruthi rs. Urol Int. 2006;77(2):130-4. doi: 10.1159/000093906. Urol Int. 2006. PMID: 16888417

10

Cyclooxygenase-2 inhibitors and other NSAIDs in urology: current peril or future promise?

Pruthi RS, Kouba E, Carson CC 3rd, Wallen EM. Pruthi RS, et al. Urology. 2006 Nov;68(5):917-23. doi: 10.1016/j.urology.2006.06.013. Urology. 2006. PMID: 17113880 Review. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

204 results

Search Page

Filters